ATLANTA, May 20 /PRNewswire/ -- Germany will present itself as one of the world's leading regenerative medicine research locations at this year's BIO International Convention. Under the "Breakthroughs in Regenerative Medicines in Germany" banner, German experts will provide invaluable insight into the latest research results in the area of regenerative medicine in Germany. The German research landscape and the regulatory framework conditions will be introduced in a presentation in which the most recent industry successes will also be demonstrated.
Dr. Manfred Rudiger, CEO of Frankfurt-based t2cure GmbH, and Prof. Dr. Georg N. Duda, Vice Director of the Berlin-Brandenburg Center for Regenerative Therapies (BCRT), will also speak at the Germany Trade & Invest-organized event. Both are experts and active partners in the German research and enterprise landscape in the area of regenerative medicine.
Regenerative medicine offers rich and varied potential at a time when western social welfare states are confronted with the problem of rapidly aging populations and overloaded health systems. It is generally expected that not only should the quality of life of the patient be improved by regenerative treatments, but also that health systems be sustainably disburdened by eliminating protracted aftercare and complications.
Germany takes center-stage in the presentation as an innovative location with favorable research conditions. In this respect, highlighted in particular is the excellent cross-linking among German universities as well as with other research and development institutions. In combination with the strong political will to actively promote promising regenerative medicine projects, the high quality of existing research networks provide a strong argument for investment in Germany.
As well as highlighting German initiative-led successes in regenerative medicine to date, the event at the Georgia World Congress Center in Atlanta will also illustrate future growth potential within the sector in Germany.
The annual BIO International Convention is the largest global event for the biotechnology industry. It takes place at changing locations within the USA and attracts participating exhibitors from around 50 countries. This year's BIO takes place until Thursday, May 21, 2009, at the Georgia World Congress Centers in Atlanta. The German Pavilion is located in Building B, Hall B2.
Germany Trade & Invest is the foreign trade and inward investment promotion agency of the Federal Republic of Germany. The organization advises and supports foreign companies seeking to expand into the German market and assists companies established in Germany looking to enter foreign markets.
http://www.gtai.com Media Contact: Eva Henkel Email: firstname.lastname@example.org Phone: +49(0)30-200099-173 Fax: +49(0)30-200099-111
|SOURCE Germany Trade and Invest|
Copyright©2009 PR Newswire.
All rights reserved